Skip to main content

Grande Alicia's Form 4 filing

Catalyst Pharmaceuticals, Inc. (CPRX) · filed Mar 30, 2023

Accession no.
0001161697-23-000200
Filed
Mar 30, 2023
Trade date
Mar 28-29, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.80M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grande AliciaCIK 0001402652Officer (VP, Treasurer and CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 28, 2023Common stock, par value $0.001 per shareMOption exerciseAcquired+58,216$0.79+$45,990.64108,773Direct
Mar 28, 2023Common stock, par value $0.001 per shareSSaleDisposed−28,216$16.60−$468,385.680,557Direct
Mar 28, 2023Common stock, par value $0.001 per shareSSaleDisposed−10,000$16.55−$165,50070,557Direct
Mar 28, 2023Common stock, par value $0.001 per shareSSaleDisposed−10,000$16.52−$165,20060,557Direct
Mar 28, 2023Common stock, par value $0.001 per shareSSaleDisposed−10,000$16.37−$163,70050,557Direct
Mar 29, 2023Common stock, par value $0.001 per shareMOption exerciseAcquired+50,000$1.13+$56,500100,557Direct
Mar 29, 2023Common stock, par value $0.001 per shareSSaleDisposed−20,000$16.72−$334,40080,557Direct
Mar 29, 2023Common stock, par value $0.001 per shareSSaleDisposed−20,000$16.70−$334,00060,557Direct
Mar 29, 2023Common stock, par value $0.001 per shareSSaleDisposed−10,000$16.67−$166,70050,557Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 28, 2023Common StockMOption exerciseDisposed−58,216$0.00$01,345,834Direct
Mar 29, 2023Common StockMOption exerciseDisposed−50,000$0.00$01,295,834Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)